Lumida
/AGIO
⌘K
Agios Pharmaceuticals Inc

Agios Pharmaceuticals Inc

AGIO
$33.60USD-0.12%-0.04 today

MARKET CAP

2.0B

P/E (TTM)

FWD P/E

DAY RANGE

$33 – $34

52W RANGE

$22
$46

AI Summary

Stalk
Buy NowMedium

AGIO is in a pronounced lockout rally driven by forced participation, with price holding above rising EMAs and the 50-day SMA. The medium-term structure remains bullish as higher lows and upward-sloping EMAs support continuation. Long-term uptrend is intact, evidenced by price above the rising 200-day SMA. Despite price extension, lockout rally dynamics justify immediate entry on shallow pullbacks into EMA and SMA confluence. Key risks include a sudden reversal if EMAs fail to hold and exhaustion of forced buying.

  • Q2 '26 revenue rose to $44.7M, driven by Acvesme launch
  • 2026 U.S. PK deficiency sales guided at $45–50M
  • Negative earnings yield and unprofitable operations hamper valuation
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income